Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02643784

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02643784
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02643784. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2017-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
Acronym
AIS
Condition
Ischemic
Intervention (Drug)
Rosuvastatin
Intervention (Other)
Control
Lead sponsor
RenJi Hospital (class: other)

Record details

Record id
cardio:ct-nct02643784
Content hash
fae10550b61f02d93390dffc8119985dbef2174f66efc00fd4125f4b3ec3aa7c